AIM
Aigen Investment Management Portfolio holdings
AUM
$730M
1-Year Return
13.63%
This Quarter Return
+3.44%
1 Year Return
+13.63%
3 Year Return
+38.05%
5 Year Return
+65.25%
10 Year Return
–
AUM
$677M
AUM Growth
-$50M
(-6.9%)
Cap. Flow
-$74M
Cap. Flow
% of AUM
-10.93%
Top 10 Holdings %
Top 10 Hldgs %
11.02%
Holding
1,031
New
439
Increased
126
Reduced
146
Closed
320
Top Buys
| 1 |
Apple
AAPL
|
$11.4M |
| 2 |
Kimberly-Clark
KMB
|
$8.5M |
| 3 |
SBA Communications
SBAC
|
$7.57M |
| 4 |
PG&E
PCG
|
$5.85M |
| 5 |
United Airlines
UAL
|
$5.73M |
Top Sells
| 1 |
Broadcom
AVGO
|
$19M |
| 2 |
Pfizer
PFE
|
$14.6M |
| 3 |
Dominion Energy
D
|
$13.4M |
| 4 |
Johnson & Johnson
JNJ
|
$12.9M |
| 5 |
Cadence Design Systems
CDNS
|
$10.5M |
Sector Composition
| 1 | Consumer Discretionary | 19.26% |
| 2 | Technology | 16.1% |
| 3 | Industrials | 11.65% |
| 4 | Financials | 11.01% |
| 5 | Healthcare | 10.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Rambus
RMBS
$8.39B
| $1.54M | 0.23% |
+23,941
| New | +$1.54M |
|
127
Vertex Pharmaceuticals
VRTX
$102B
| $1.53M | 0.23% |
+4,358
| New | +$1.53M |
|
128
Nu Holdings
NU
$73.1B
| $1.52M | 0.23% |
193,096
+59,268
| +44% | +$468K |
|
129
Integra LifeSciences
IART
$1.24B
| $1.52M | 0.22% |
+36,952
| New | +$1.52M |
|
130
Apollo Global Management
APO
$76.9B
| $1.51M | 0.22% |
19,713
-20,441
| -51% | -$1.57M |
|
131
T Rowe Price
TROW
$24.5B
| $1.51M | 0.22% |
13,460
-55,375
| -80% | -$6.2M |
|
132
Designer Brands
DBI
$216M
| $1.47M | 0.22% |
145,831
+23,319
| +19% | +$236K |
|
133
Novo Nordisk
NVO
$247B
| $1.45M | 0.21% |
+17,904
| New | +$1.45M |
|
134
Franco-Nevada
FNV
$36.9B
| $1.43M | 0.21% |
+10,059
| New | +$1.43M |
|
135
CRH
CRH
$75.1B
| $1.43M | 0.21% |
+25,718
| New | +$1.43M |
|
136
Newmont
NEM
$83.2B
| $1.43M | 0.21% |
33,568
+8,200
| +32% | +$350K |
|
|
RVNC
137
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.37M | 0.2% |
53,988
+42,150
| +356% | +$1.07M |
|
138
Ford
F
$47B
| $1.37M | 0.2% |
90,268
-68,047
| -43% | -$1.03M |
|
139
Nu Skin
NUS
$608M
| $1.36M | 0.2% |
+41,051
| New | +$1.36M |
|
|
AXNX
140
DELISTED
Axonics, Inc. Common Stock
AXNX
| $1.36M | 0.2% |
+26,959
| New | +$1.36M |
|
|
SWAV
141
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $1.36M | 0.2% |
+4,758
| New | +$1.36M |
|
142
Advanced Micro Devices
AMD
$250B
| $1.35M | 0.2% |
+11,884
| New | +$1.35M |
|
143
Uber
UBER
$191B
| $1.35M | 0.2% |
31,291
+20,158
| +181% | +$870K |
|
144
Brighthouse Financial
BHF
$2.54B
| $1.35M | 0.2% |
+28,493
| New | +$1.35M |
|
|
ROIC
145
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $1.35M | 0.2% |
99,668
+42,240
| +74% | +$571K |
|
146
NextEra Energy, Inc.
NEE
$147B
| $1.33M | 0.2% |
+17,875
| New | +$1.33M |
|
147
MarketAxess Holdings
MKTX
$6.91B
| $1.32M | 0.2% |
+5,063
| New | +$1.32M |
|
148
MetLife
MET
$54.5B
| $1.32M | 0.2% |
+23,384
| New | +$1.32M |
|
149
HCA Healthcare
HCA
$96.2B
| $1.28M | 0.19% |
+4,232
| New | +$1.28M |
|
150
Duolingo
DUOL
$12.2B
| $1.27M | 0.19% |
8,903
+174
| +2% | +$24.9K |
|